Use access key #2 to skip to page content.
$52.73 1.04 (2.01%)
7/18/2008 1:33 PM

Gen-Probe, Inc. (GPRO)

CAPS Rating:
*****

The Company is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid probe-based products used for the clinical diagnosis of human diseases and for screening donated human blood.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating GPRO

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

186 Outperforms
6 Underperforms
 

All-Stars

79 Outperforms
4 Underperforms
 

Wall Street

14 Outperforms
0 Underperforms
 

Players bullish on GPRO are also bullish on:

Players bearish on GPRO are also bearish on:

Ticker Tags

Medical Diagnostic Equipment (10), Research Services (46), Small Cap (1922), In Vitro Diagnostics (1)
Suggest a tag

Gen-Probe, Inc. At A Glance

Current Price: $52.73
Last Trade Time: 7/18/2008 1:33 PM
Open: $51.80
Previous Close: $51.69
Daily Range: $51.68 - $52.73
52-Week Range: $44.82 - $71.84
Volume: 439,979
Market Cap: $2.79B
P/E Ratio: 28.56
Compare Our Special Broker Offers!

Stock Trends

GPRO VS S&P 500 (SPY)

GPRO 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for GPRO

More Headlines...

Top Bull Pitch

Recs

1

Gen-Probe, Inc. (GPRO)

Avatar doggetla (69.57) Submitted: 3/24/08 6:49 PM

just "discovered" this stock, healthcare is the sector to be in during a recession.

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 20 :   1 2 3 4 Next »

Recs

0

 (GPRO)

Avatar pilotg2 (< 20) Submitted: 7/17/08 2:26 PM : Outperform Start Price: $51.91 GPRO Score: 1.44

Close to its target price, I think it still has some more room. Its indicators are still showing strong upward growth as well.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GPRO)

Avatar ScreenerStiz (< 20) Submitted: 6/26/08 2:02 PM : Outperform Start Price: $48.97 GPRO Score: 10.02

I simply used the screener to find all of the 5 star stocks with the greatest 52-week losses. 5 stars should make them good picks and the high 52-week loss should make them cheap. We’ll see how it works!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GPRO)

Avatar apache23 (56.53) Submitted: 4/24/08 6:37 AM : Outperform Start Price: $53.88 GPRO Score: 5.64

agen

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GPRO)

Avatar BigSteve590 (90.83) Submitted: 3/27/08 9:02 AM : Outperform Start Price: $48.31 GPRO Score: 14.90

Gen-Probe is a leader in molecular diagnostics. It has tests for HIV and Hepatitis B and C, and is developing a more-reliable prostate cancer screening test.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (GPRO)

Avatar doggetla (69.57) Submitted: 3/24/08 6:49 PM : Outperform Start Price: $49.00 GPRO Score: 13.83

just "discovered" this stock, healthcare is the sector to be in during a recession.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 20 :   1 2 3 4 Next »

Wall Street

Results 1 - 14 of 14  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackWMBlair 21.82 06/10/08 Outperform NS $51.94+0.71%-7.63%+8.34
TrackCarisandCo 78.93 04/29/08 Outperform NS $56.84-7.97%-10.20%+2.23
TrackRBCCapMkts 93.95 04/23/08 Outperform NS $54.30-3.66%-9.37%+5.71
TrackDeutscheSec 89.41 11/15/07 Outperform NS $63.32-17.39%-14.50%-2.89
TrackSoros 86.25 09/30/07 Outperform NS $66.58-21.43%-17.86%-3.57 Toggle the visibility of 60-Second Pitch and replies
TrackRonBaron 25.23 09/30/07 Outperform NS $66.58-21.43%-17.86%-3.57 Toggle the visibility of 60-Second Pitch and replies
TrackFerrisBaker 89.26 08/02/07 Outperform NS $65.18-19.75%-14.31%-5.44
TrackJimCramer 82.43 07/12/07 Outperform 3W $59.98-12.79%-18.83%+6.04
TrackGarpResearc 65.80 04/17/07 Outperform NS $50.73+3.11%-14.81%+17.93
TrackBofASec 96.82 04/13/07 Outperform NS $49.06+6.62%-13.50%+20.12
Track2007Wired40 94.92 03/27/07 Outperform 1Y $47.30+10.59%-12.28%+22.87
TrackLehmanBros 87.62 11/20/06 Outperform NS $49.25+6.21%-10.64%+16.85
TrackRWBaird 91.31 10/04/06 Outperform NS $46.45+12.62%-5.75%+18.37
Track2006Wired40 96.46 06/27/06 Outperform 1Y $51.33+1.91%+1.17%+0.74

Results 1 - 14 of 14  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners